Pacific Biosciences of California, Inc. (PACB) Posts Q3 EPS Loss of $0.54, Sales Top Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 2.11 +0.05 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $14.00 | |||
| Open | $2.02 | 52 Week Low | $6.61 | |||
| Day High | $2.13 | P/E | N/A | |||
| Day Low | $1.97 | EPS | $-1.26 | |||
| Volume | 5,715,766 | |||||
